Cargando…

Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis

The aim of this study is to elucidate the prognostic factors and the treatment effect on survival in hepatocellular carcinoma (HCC) patients with Child C cirrhosis. Out of 3330 newly discovered HCC patients, 157 consecutive HCC individuals with Child C cirrhosis were enrolled. The prognostic factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nouso, K, Ito, Y M, Kuwaki, K, Kobayashi, Y, Nakamura, S, Ohashi, Y, Yamamoto, K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359634/ https://www.ncbi.nlm.nih.gov/pubmed/18349849 http://dx.doi.org/10.1038/sj.bjc.6604282

Ejemplares similares

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
por: Miyahara, K, et al.
Publicado: (2013)

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis
por: Thompson Coon, J, et al.
Publicado: (2008)

Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis
por: Nosho, K, et al.
Publicado: (2005)

Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis—prevalence and risk factors
por: Siddiqui, Muhammad Tayyab Ul-Hasan, et al.
Publicado: (2023)

Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000)

Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan
por: Nouso, K, et al.
Publicado: (2013)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy
por: Li, J, et al.
Publicado: (2014)

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
por: Nagai, Hidenari, et al.
Publicado: (2012)

A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis
por: Biselli, M, et al.
Publicado: (2015)

Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma
por: Miyoshi, A, et al.
Publicado: (2005)

Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapy
por: Hamada, T, et al.
Publicado: (2014)

Validation of a new prognostic index score for disseminated nasopharyngeal carcinoma
por: Toh, C-K, et al.
Publicado: (2005)

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
por: Santoro, A, et al.
Publicado: (2013)

Prognostic Factors in Cutaneous Squamous Cell Carcinoma: Is Patient Delay in Hospital Visit a Predictor of Survival?
por: Endo, Y., et al.
Publicado: (2011)

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma
por: Chow, P K H, et al.
Publicado: (2011)

Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma
por: Fan, L, et al.
Publicado: (2013)

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
por: Tian, Y-M, et al.
Publicado: (2014)

Prognostic impact of histological categorisation of epithelial–mesenchymal transition in colorectal cancer
por: Ueno, H, et al.
Publicado: (2014)

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
por: Tandon, Puneeta, et al.
Publicado: (2009)

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma
por: Zhang, B, et al.
Publicado: (2013)

Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
por: Schoenleber, S J, et al.
Publicado: (2009)

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
por: Shao, Y-Y, et al.
Publicado: (2012)

Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial
por: Seto, T, et al.
Publicado: (2006)

Hepatitis B virus subgenotype C2- and B2-associated mutation patterns may be responsible for liver cirrhosis and hepatocellular carcinoma, respectively
por: Chen, Y.M., et al.
Publicado: (2013)

Clinical Significance and Prognostic Impact of Subcutaneous or Intrastrap Muscular Recurrence of Papillary Thyroid Carcinoma
por: Ito, Yasuhiro, et al.
Publicado: (2012)

Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
por: Lee, D-W, et al.
Publicado: (2013)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis
por: Nakanishi, Yutaka, et al.
Publicado: (2011)

Prospective validation of quantitative CEA mRNA detection in peritoneal washes in gastric carcinoma patients
por: Ito, S, et al.
Publicado: (2005)

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
por: Palmer, D H, et al.
Publicado: (2013)

CYP2C19 genotype-based phase I studies of a c-Met inhibitor tivantinib in combination with erlotinib, in advanced/metastatic non-small cell lung cancer
por: Yamamoto, N, et al.
Publicado: (2013)

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03
por: Kishida, Y, et al.
Publicado: (2009)

Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies
por: Toi, M, et al.
Publicado: (2009)

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: KATAOKA, JUNRO, et al.
Publicado: (2016)

Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma
por: Kataoka, Junro, et al.
Publicado: (2017)

Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis
por: Ishioka, J, et al.
Publicado: (2012)

Angiogenic Factor Expression in Hepatic Cirrhosis
por: Giatromanolaki, Alexandra, et al.
Publicado: (2007)

Prognostic value of magnetic resonance imaging-detected cranial nerve invasion in nasopharyngeal carcinoma
por: Liu, X, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f5pnbqcfs7obulpnd2idfucrri